Wells Fargo & Company MN Sells 5,009 Shares of Abrdn Healthcare Investors (NYSE:HQH)

Wells Fargo & Company MN trimmed its position in shares of Abrdn Healthcare Investors (NYSE:HQH) by 56.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,868 shares of the financial services provider’s stock after selling 5,009 shares during the quarter. Wells Fargo & Company MN’s holdings in Abrdn Healthcare Investors were worth $62,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Landscape Capital Management L.L.C. bought a new position in Abrdn Healthcare Investors in the 4th quarter worth $573,000. Prevail Innovative Wealth Advisors LLC bought a new position in Abrdn Healthcare Investors in the 4th quarter worth $590,000. Brown Brothers Harriman & Co. bought a new position in Abrdn Healthcare Investors in the 4th quarter worth $48,000. LPL Financial LLC raised its holdings in Abrdn Healthcare Investors by 65.3% in the 4th quarter. LPL Financial LLC now owns 282,020 shares of the financial services provider’s stock worth $4,526,000 after purchasing an additional 111,383 shares during the period. Finally, Samalin Investment Counsel LLC raised its holdings in Abrdn Healthcare Investors by 7.2% in the 4th quarter. Samalin Investment Counsel LLC now owns 72,844 shares of the financial services provider’s stock worth $1,169,000 after purchasing an additional 4,875 shares during the period. 32.60% of the stock is owned by institutional investors.

Abrdn Healthcare Investors Stock Down 1.9%

Shares of Abrdn Healthcare Investors stock opened at $15.33 on Wednesday. Abrdn Healthcare Investors has a one year low of $13.77 and a one year high of $19.79. The stock’s fifty day moving average is $15.83 and its 200 day moving average is $16.84.

About Abrdn Healthcare Investors

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.